A PYMNTS Company

US: Lawyers announced as antitrust counsel to Pfizer

By  |  November 24, 2015

Morgan Lewis is serving as lead US antitrust counsel to Pfizer in its proposed combination with Allergan, which will establish a new global biopharmaceutical leader.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The Morgan Lewis team is led by partners Scott Stempel and Harry Robins. Support is provided by partner Clay Everett and associates David Brenneman, Martin d’Halluin, Katie Glynn, and Maria Luisa Di Lauro.

    When completed, the transaction will be the largest pharmaceutical industry M &A transaction in history and among the largest M &A transactions of any type. Including this deal, the Morgan Lewis antitrust team has worked on three of the seven largest pharmaceutical transactions ever.

    Full content: Pfizer

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.